ArticleBMC plant biology2026
Adaptation of lipid metabolism of the polyextremophilic cyanobacterium Cyanobacterium aponinum PCC 10605 to adverse environmental conditions.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCyanobacterium aponinum PCC 10605 (Cyan10605), a thermophilic, halotolerant single-cell cyanobacterium, can grow under extreme conditions including high temperature and high salinity. While the impact of stress on growth and the production of biotechnologically high-value compounds like exopolysaccharides and phycocyanin have been studied, the responses of lipid metabolism of Cyan10605 under stress conditions remain unclear.
resultsHere, we present the alterations in membrane and nonpolar lipids in Cyan10605 cells during growth under high temperature, salt stress, phosphate and nitrogen deprivation, and extended cultivation time. The degree of acyl unsaturation in all membrane lipid classes decreased at high temperature, while sulfolipids accumulated up to ~ 50 mol% of membrane lipids at the expense of galactolipids in cells grown in artificial seawater medium. The membrane lipid composition under phosphate deprivation remained similar, with low amounts of phosphatidylglycerol, while the proportion of sulfolipid was increased under nitrogen starvation. After extended cultivation, large amounts of membrane lipids were degraded. Triacylglycerol containing saturated acyl groups accumulated at high temperatures, while under phosphate deprivation, the TAG content remained similar, but fatty acid phytyl esters increased. Nitrogen deprivation caused an increase in TAG but a decrease in phytyl esters. After extended cultivation, triacylglycerol and phytyl esters accumulated to the highest amounts. Under all stress conditions, the content of acyl-plastoquinols decreased. Cyan10605 contains a multifunctional acyltransferase related to Synechocystis sp. PCC 6803 Slr2103. This enzyme is presumably involved in nonpolar lipid synthesis since it produced TAG and FAPE after expression in Escherichia coli.
conclusionsThese results show that membrane lipids and nonpolar lipids are involved in the metabolic response of Cyan10605 to adapt to extreme growth conditions. Small amounts of fatty acids derived from membrane lipids are deposited in the form of TAG and FAPE, but not in acyl-plastoquinols, during extended cultivation, indicating that the synthesis of nonpolar lipid classes is differentially regulated. Knowledge about lipid changes during adaptation to different growth conditions is crucial for biotechnological applications including the use of Cyan10605 for biodiesel production and the optimization of growth in outdoor or mass cultivation settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.